Intrinsic Value of S&P & Nasdaq Contact Us

Caris Life Sciences, Inc. CAI NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
$31.30
+55%
Analyst Price Target
$31.33
+55.2%

Stock Statistics — CAI

Caris Life Sciences, Inc. (CAI) has a market capitalization of $5.71B and trades at $20.19. The 52-week range is 16.28-42.5.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -10.6, Earnings Per Share (EPS) of $-1.90, annual revenue of $812.03M.

The stock has a beta of 1.09, operates in the Healthcare sector.

Trading Data
Current Price$20.19
52-Week Range16.28-42.5
Volume1.97M
Avg Volume (30D)2.48M
Market Cap$5.71B
Beta (1Y)1.09
Company
IPO Date2025-06-18
Employees1,769
CEODavid Dean Halbert
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS1421521071
CUSIP142152107
Income (Latest Year)
Revenue$812.03M
Gross Profit$539.17M
EBITDA$11.38M
Operating Income$45.11M
Net Income$-537.96M
EPS$-1.90
EPS Diluted$-1.90
Shares Outstanding$1.67B
Balance Sheet (Latest Year)
Total Assets$1.13B
Current Assets$997.8M
Cash & ST Investments$800.09M
Total Liabilities$548.36M
Total Debt$378.99M
Net Debt$-418.81M
Total Equity$577.31M
Debt / Equity0.66
Valuation Ratios
P/E Ratio-10.6
P/S Ratio7.03
P/B Ratio9.88
EV/EBITDA (approx)501.3
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message